A case of iloperidone overdose in a 27-year-old man with cocaine abuse
- PMID: 27570623
- PMCID: PMC4984480
- DOI: 10.1177/2050313X16660485
A case of iloperidone overdose in a 27-year-old man with cocaine abuse
Abstract
Introduction: Iloperidone is a recently introduced antipsychotic medication. It is approved for the treatment of schizophrenia. There are no published reports of iloperidone overdosage, but there are eight cases that have been reported to the US Food and Drug Administration.
Case report: A case of a 27-year-old man who took 84 mg of iloperidone while also smoking cocaine is described. He developed a prolonged QTc (527 ms) without arrhythmias and respiratory failure with mandated respiratory support. He ultimately recovered without sequelae.
Discussion: The information regarding previous cases of toxicity on the US Food and Drug Administration website is incomplete. However, there were no fatalities due to iloperidone over-ingestion. Prolongation of the QTc may be a common feature.
Keywords: Iloperidone; QT; QTc; overdosage; toxicity.
Conflict of interest statement
Similar articles
-
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.J Clin Psychopharmacol. 2013 Feb;33(1):3-10. doi: 10.1097/JCP.0b013e31827c0314. J Clin Psychopharmacol. 2013. PMID: 23277250 Clinical Trial.
-
Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.Pharmacol Res. 2012 Jul;66(1):60-5. doi: 10.1016/j.phrs.2012.03.008. Epub 2012 Mar 23. Pharmacol Res. 2012. PMID: 22465688
-
Safety profile of iloperidone in the treatment of schizophrenia.Expert Opin Drug Saf. 2014 Feb;13(2):241-6. doi: 10.1517/14740338.2014.854770. Epub 2013 Nov 11. Expert Opin Drug Saf. 2014. PMID: 24206391 Review.
-
Iloperidone: A new drug for the treatment of schizophrenia.Am J Health Syst Pharm. 2011 Feb 15;68(4):301-8. doi: 10.2146/ajhp100079. Am J Health Syst Pharm. 2011. PMID: 21289324 Review.
-
Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.Clin Toxicol (Phila). 2015 May;53(4):204-9. doi: 10.3109/15563650.2015.1013547. Epub 2015 Feb 23. Clin Toxicol (Phila). 2015. PMID: 25706450
References
-
- Citrome L, Meng X, Hochfeld M, et al. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials. Hum Psychopharmacol 2012; 27(1): 24–32. - PubMed
-
- Potkin SG, Preskorn S, Hochfeld M, et al. A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone. J Clin Psychopharmacol 2013; 33(1): 3–10. - PubMed
-
- Hasnain M, Vieweg WV. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs 2014; 28(10): 887–920. - PubMed
-
- Vigneault P, Pilote S, Patoine D, et al. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration. Pharmacol Res 2012; 66(1): 60–65. - PubMed
-
- Levine M, Iliescu ME, Margellos-Anast H, et al. The effects of cocaine and heroin use on intubation rates and hospital utilization in patients with acute asthma exacerbations. Chest 2005; 128(4): 1951–1957. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources